EDAP TMS S.A. Signs Exclusive Distribution Alliance with China Medical to Launch Their HIFU Devices in European Union and Russia

LYON, France, April 30 /PRNewswire-FirstCall/ -- EDAP TMS S.A. (Nasdaq: EDAP - News), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer and China Medical Technologies, Inc. (Nasdaq: CMED - News), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic systems and HIFU products, today announced an exclusive agreement in which EDAP will distribute China Medical's HIFU tumor therapy systems in the European Union (EU) and Russia.